Galectin-3 and peripheral artery disease: a Mendelian randomization study

BackgroundMultiple clinical studies have found a significant correlation between elevated galectin-3 (Gal-3) in circulation and the diagnosis and severity of peripheral arterial disease (PAD). The current study used the Mendelian randomization (MR) technique to evaluate the possible causal relations...

Full description

Bibliographic Details
Main Authors: Yang Gou, Miao Chen, Zhi Zhu, Chi Cui
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1279396/full
_version_ 1827391116057509888
author Yang Gou
Miao Chen
Zhi Zhu
Chi Cui
author_facet Yang Gou
Miao Chen
Zhi Zhu
Chi Cui
author_sort Yang Gou
collection DOAJ
description BackgroundMultiple clinical studies have found a significant correlation between elevated galectin-3 (Gal-3) in circulation and the diagnosis and severity of peripheral arterial disease (PAD). The current study used the Mendelian randomization (MR) technique to evaluate the possible causal relationship between Gal-3 and PAD.MethodsGenome-wide association study (GWAS) data of Gal-3 and PAD were obtained through the MR-Base platform. Then, using Gal-3 as the exposure and PAD as the outcome, a two-sample MR analysis was performed utilizing several regression techniques, including MR-Egger regression, inverse variance weighted (IVW), weighted median, and weighted mode.ResultsSix single-nucleotide polymorphisms (SNPs) were identified and designated as instrumental variables (IVs) that exhibited significant correlations with Gal-3 (linkage disequilibrium r2 < 0.001; P < 5 × 10−8). Various statistical methods showed that there was an absence of a significant link between Gal-3 and PAD (IVW: odds ratio (OR) = 0.9869, 95% confidence interval (CI) = 0.8792–1.1078, P = 0.8232). In addition, the presence of genetic pleiotropy did impact the putative causal relationship between PAD and Gal-3 (MR-Egger intercept = 0.0099, P = 0.659).ConclusionsThere is no current evidence to establish a causal relationship between the level of Gal-3 in circulation and PAD.
first_indexed 2024-03-08T17:06:02Z
format Article
id doaj.art-880cee07daad414da82573b62a2aa3d9
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-03-08T17:06:02Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-880cee07daad414da82573b62a2aa3d92024-01-04T05:07:04ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2024-01-011010.3389/fcvm.2023.12793961279396Galectin-3 and peripheral artery disease: a Mendelian randomization studyYang GouMiao ChenZhi ZhuChi CuiBackgroundMultiple clinical studies have found a significant correlation between elevated galectin-3 (Gal-3) in circulation and the diagnosis and severity of peripheral arterial disease (PAD). The current study used the Mendelian randomization (MR) technique to evaluate the possible causal relationship between Gal-3 and PAD.MethodsGenome-wide association study (GWAS) data of Gal-3 and PAD were obtained through the MR-Base platform. Then, using Gal-3 as the exposure and PAD as the outcome, a two-sample MR analysis was performed utilizing several regression techniques, including MR-Egger regression, inverse variance weighted (IVW), weighted median, and weighted mode.ResultsSix single-nucleotide polymorphisms (SNPs) were identified and designated as instrumental variables (IVs) that exhibited significant correlations with Gal-3 (linkage disequilibrium r2 < 0.001; P < 5 × 10−8). Various statistical methods showed that there was an absence of a significant link between Gal-3 and PAD (IVW: odds ratio (OR) = 0.9869, 95% confidence interval (CI) = 0.8792–1.1078, P = 0.8232). In addition, the presence of genetic pleiotropy did impact the putative causal relationship between PAD and Gal-3 (MR-Egger intercept = 0.0099, P = 0.659).ConclusionsThere is no current evidence to establish a causal relationship between the level of Gal-3 in circulation and PAD.https://www.frontiersin.org/articles/10.3389/fcvm.2023.1279396/fullgalectin-3peripheral artery diseaseMendelian randomizationcausalitySNPs (single-nucleotide polymorphisms)
spellingShingle Yang Gou
Miao Chen
Zhi Zhu
Chi Cui
Galectin-3 and peripheral artery disease: a Mendelian randomization study
Frontiers in Cardiovascular Medicine
galectin-3
peripheral artery disease
Mendelian randomization
causality
SNPs (single-nucleotide polymorphisms)
title Galectin-3 and peripheral artery disease: a Mendelian randomization study
title_full Galectin-3 and peripheral artery disease: a Mendelian randomization study
title_fullStr Galectin-3 and peripheral artery disease: a Mendelian randomization study
title_full_unstemmed Galectin-3 and peripheral artery disease: a Mendelian randomization study
title_short Galectin-3 and peripheral artery disease: a Mendelian randomization study
title_sort galectin 3 and peripheral artery disease a mendelian randomization study
topic galectin-3
peripheral artery disease
Mendelian randomization
causality
SNPs (single-nucleotide polymorphisms)
url https://www.frontiersin.org/articles/10.3389/fcvm.2023.1279396/full
work_keys_str_mv AT yanggou galectin3andperipheralarterydiseaseamendelianrandomizationstudy
AT miaochen galectin3andperipheralarterydiseaseamendelianrandomizationstudy
AT zhizhu galectin3andperipheralarterydiseaseamendelianrandomizationstudy
AT chicui galectin3andperipheralarterydiseaseamendelianrandomizationstudy